Renaissance Technologies’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Buy |
195,700
+22,600
| +13% | +$316K | ﹤0.01% | 1915 |
|
|
2025
Q1 | $2.35M | Buy |
+173,100
| New | +$2.35M | ﹤0.01% | 1900 |
|
|
2024
Q1 | – | Sell |
-161,946
| Closed | -$3.48M | – | 3778 |
|
|
2023
Q4 | $3.48M | Sell |
161,946
-305,905
| -65% | -$6.56M | 0.01% | 1581 |
|
|
2023
Q3 | $9.65M | Buy |
467,851
+51
| +0% | +$1.05K | 0.02% | 944 |
|
|
2023
Q2 | $13.8M | Buy |
467,800
+59,700
| +15% | +$1.76M | 0.02% | 860 |
|
|
2023
Q1 | $9.4M | Buy |
408,100
+158,500
| +64% | +$3.65M | 0.01% | 1114 |
|
|
2022
Q4 | $6.94M | Sell |
249,600
-142,600
| -36% | -$3.97M | 0.01% | 1301 |
|
|
2022
Q3 | $12M | Buy |
392,200
+138,700
| +55% | +$4.26M | 0.02% | 932 |
|
|
2022
Q2 | $7.46M | Buy |
253,500
+130,900
| +107% | +$3.85M | 0.01% | 1281 |
|
|
2022
Q1 | $3.94M | Buy |
122,600
+68,300
| +126% | +$2.2M | ﹤0.01% | 1757 |
|
|
2021
Q4 | $2.42M | Sell |
54,300
-41,300
| -43% | -$1.84M | ﹤0.01% | 1988 |
|
|
2021
Q3 | $4.82M | Buy |
95,600
+84,100
| +731% | +$4.24M | 0.01% | 1485 |
|
|
2021
Q2 | $902K | Sell |
11,500
-254,400
| -96% | -$20M | ﹤0.01% | 2718 |
|
|
2021
Q1 | $15.2M | Buy |
+265,900
| New | +$15.2M | 0.02% | 937 |
|
|
2020
Q4 | – | Sell |
-51,500
| Closed | -$1.85M | – | 3443 |
|
|
2020
Q3 | $1.85M | Buy |
+51,500
| New | +$1.85M | ﹤0.01% | 2187 |
|
|
2019
Q3 | – | Sell |
-63,000
| Closed | -$1.31M | – | 3468 |
|
|
2019
Q2 | $1.31M | Buy |
+63,000
| New | +$1.31M | ﹤0.01% | 2564 |
|